Skip to content
DataLookout
Menu

NCT04060030

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

StatusActive, Not Recruiting
PhasePhase 2
Primary completion (estimated)

At risk: Primary completion moved 6 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jul 31, 2026 to Jan 31, 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 32 words
    • Enrollment closed, study ongoing
    • Secondary endpoints: details revised at 13 of 13 entries
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 5 of 5 entries
  2. Notable Primary and study completion dates pushed to Jul 31, 2026v10
  3. Notable Primary completion date: Jan 2025 to Dec 2025
    • Study completion date: Jan 2025 to Jun 2026
    v9
  4. Minor Site contacts updated at 2 of 2 sitesv8
  5. Notable Lead sponsor: Rossignol Medical Center to Southwest Autism Research & Resource Center
    • Primary and study completion dates: Dec 2023 to Jan 2025
    • Secondary endpoints revised (13)
    • Collaborators: 3 to 2
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 2 of 2 sites
    v6
  2. Notable Lead sponsor: Phoenix Children's Hospital to Rossignol Medical Centerv5 Show 5 more changesShow less
    • Primary and study completion dates: Dec 2022 to Dec 2023
    • Eligibility criteria expanded, about 21 words
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites revised (2)
    • Collaborators: 4 to 3
  3. Notable Trial status: Not Yet Recruiting to Recruitingv4 Show 5 more changesShow less
    • Eligibility criteria expanded, about 204 words
    • Primary endpoint revised
    • Start date changed from estimate of Oct 2020 to Oct 8, 2020
    • Secondary endpoints: 12 to 13
    • Site details revised at 2 of 2 sites
  4. Notable Primary and study completion dates: Dec 2021 to Dec 2022
    • Start date: May 2020 to Oct 2020
    v3
  5. Notable Start date: Dec 2019 to May 2020v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Evaluate the change in social communication symptoms
Timeframe: Baseline, Week 6, Week 12, Week 24

Secondary (13)

Evaluate the safety and tolerability of L-leucovorin calcium in young children with ASD
Evaluate adverse effect symptoms in young children with ASD
Evaluate the biologic safety of L-leucovorin calcium in young children with ASD
Evaluate the safety of L-leucovorin calcium in young children with ASD on antiepileptic drugs
Examine the change in measures of Expressive and Receptive Language
Show 8 moreShow less
Evaluate the change in effects of autism symptoms on family members
Evaluate the change in stereotypical autism symptoms
Evaluate change in overall autism severity
Evaluate change in specific autism symptom severity
Evaluate the change in overall cognitive ability
Evaluate the change in adaptive functioning
Evaluate the overall change in core ASD symptoms of social communication
Evaluate the overall change in core ASD symptoms of social communication using a blind observer

Arms and interventions

L-leucovorin calciumExperimental

The liquid form of leucovorin calcium will be dosed by weight, with a target dose of 1mg/kg/day, divided into two daily doses. This product may be taken alone or mixed with liquid. Participants randomized to this arm will receive active treatment for both 12-week phases of the study.

PlaceboPlacebo comparator

The placebo will mimic the experimental treatment in flavor, odor, packaging, and dosing instructions. Participants randomized to this arm will receive placebo for the first 12 weeks of the study, then active treatment for the remaining 12 weeks.

Drugs: Levoleucovorin Calcium

Other: Placebo

Sites

2 sites in 1 country